Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model

Transplantation

Volumn 87, Issue 12, 2009, Pages 1769-1777

  Kuo, Yur Ren ^a   Goto, Shigeru ^a   Shih, Hsiang Shun ^a   Wang, Feng Sheng ^a   Lin, Chien Chih ^a   Wang, Chun Ting ^a   Huang, Eng Yen ^a   Chen, Chao Long ^a   Wei, Fu Chan ^a   Zheng, Xin Xiao ^b   Lee, W P Andrew ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Composite tissue allotransplant; Mesenchymal stem cells

Indexed keywords

CYCLOSPORIN A;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COMPOSITE GRAFT; CONTROLLED STUDY; ECTOPIC TISSUE; EXPERIMENTAL MODEL; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HETEROTOPIC TRANSPLANTATION; HINDLIMB; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYCLOSPORINE; FEMUR; FIBULA; GRAFT SURVIVAL; HINDLIMB; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; SWINE; SWINE, MINIATURE; T-LYMPHOCYTES; TIBIA; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 67649586583     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a664f1     Document Type: Article

References (33)

1. Lee WP. Composite tissue transplantation: More science and patience needed. Plast Reconstr Surg 2001; 107: 1066.
2. Jones NF. Concerns about human hand transplantation in the 21st century. J Hand Surg [Am] 2002; 27: 771.
3. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: Report on first 6 months. Lancet 1999; 353: 1315.
4. Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. New England J Med 2000; 343: 468.
5. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007; 357: 2451.
6. Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401.
7. Kanitakis J. The challenge of dermatopathological diagnosis of composite tissue allograft rejection: A review. J Cutan Pathol 2008; 35: 738.
8. Madani H, Hettiaratchy S, Clarke A, et al. Immunosuppression in an emerging field of plastic reconstructive surgery: Composite tissue allotransplantation. J Plast Reconstr Aesthet Surg 2008; 61: 245.
9. Prabhune KA, Gorantla VS, Maldonado C, et al. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 2000; 20: 441.
10. Gale RP. Graft versus host disease. Immunol Rev 1985; 88: 193.
11. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000; 28: 875.
12. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143.
13. Majumdar MK, Keane-Moore M, Buyaner D, et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003; 10: 228.
14. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722.
15. Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821.
16. Ringde'n O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 1390.
17. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
18. Aroni K, Tsagroni E, Kavantzas N, et al. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res 2008; 300: 115.
19. Wu CY, Jiang YN, Chu HP, et al. The type I Lanyu pig has a maternal genetic lineage distinct from Asian and European pigs. Anim Genet 2007; 38: 499.
20. Chu HP. Selection and utilization of indigenous mini-pig. Presented at 2006 Symposium COA/INRA Scientific Cooperation in Agriculture, Tainan, Taiwan, R.O.C, 2006.
21. Kuo YR, Sacks JM, Wu WS, et al. Porcine heterotopic composite tissue allograft transplantation as a large animal model for pre-clinical study. Chang Gung Med J 2006; 29: 268.
22. Lee WP, Rubin JP, Cober S, et al. Use of swine model in transplantation of vascularized skeletal tissue allografts. Transplant Proc 1998; 30: 2743.
23. Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004; 33: 597.
24. Zdichavsky M, Jones JW, Ustuner ET, et al. Scoring of skin rejection in a swine composite tissue allograft model. J Surg Res 1999; 85: 1.
25. Cendales LC, Kirk AD, Moresi M, et al. Composite tissue allotransplantation: Classification of clinical acute skin rejection. Transplantation 2005; 80: 1676.
26. Cendales LC, Kanitakis J, Schneebergerc S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396.
27. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allograft or xenografts. Nature 1984; 307: 168.
28. Lee WP, Rubin JP, Bourget JL, et al. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens. Plast Reconstr Surg 2001; 107: 1482.
29. Siemionow M, Ortak T, Izycki D, et al. Induction of tolerance in composite-tissue allografts. Transplantation 2002; 74: 1211.
30. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003; 75: 25.
31. Takashi E, Muneo I, Naoya I, et al. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 2003; 76: 1543.
32. Ozmen S, Ulusal BG, Ulusal AE, et al. Composite vascularized skin/ bone transplantation models for bone marrow-based tolerance studies. Ann Plast Surg 2006; 56: 295.
33. Arslan E, Klimczak A, Siemionow M. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells. Microsurgery 2007; 27: 190.